TI
SRPT icon

Tidal Investments’s Sarepta Therapeutics SRPT Stock Holding History

Tidal Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
+10,193
New +$193K ﹤0.01% 2476
2025
Q1 		– Sell
-2,972
Closed -$361K – 2010
2024
Q4 		$361K Sell
2,972
-2,662
-47% -$326K ﹤0.01% 1525
2024
Q3 		$704K Buy
5,634
+2,688
+91% +$372K 0.01% 1210
2024
Q2 		$465K Buy
2,946
+44
+2% +$5.65K 0.01% 1335
2024
Q1 		$376K Buy
2,902
+228
+9% +$27.9K 0.01% 1311
2023
Q4 		$258K Buy
2,674
+735
+38% +$70.5K 0.01% 1235
2023
Q3 		$235K Buy
1,939
+111
+6% +$12.5K 0.01% 1152
2023
Q2 		$209K Buy
+1,828
New +$236K 0.01% 1190

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Tidal Investments's SRPT Position: Q2 2026 in Review

Tidal Investments opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 10,193 shares worth $183K. The stake represents ﹤0.01% of the portfolio and ranks #2476 among its holdings. This is a return to the name: Tidal Investments previously reported a position in SRPT as recently as Q4 2024.

Tidal Investments first reported a position in SRPT in Q2 2023 and has held it in 8 quarters since. The position peaked at $704K in Q3 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Tidal Investments held 10,193 shares of Sarepta Therapeutics worth $183K as of Q2 2026.
  • Sarepta Therapeutics was a new Tidal Investments position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2476 holding.
  • Tidal Investments first reported a position in Sarepta Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • Tidal Investments's Sarepta Therapeutics position peaked at $704K in Q3 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.